Dogwood Therapeutics, Inc. (DWTX) vs Fractyl Health, Inc. (GUTS)

A side-by-side comparison of Dogwood Therapeutics, Inc. and Fractyl Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Dogwood Therapeutics, Inc. logo
DWTX
Dogwood Therapeutics, Inc.
$52M
$1.56HealthcareDelayed quote: Oct 6, 2026, 12:35 PM EDT
Fractyl Health, Inc. logo
GUTS
Fractyl Health, Inc.
$59M
$4.43HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT

Total return — DWTX vs GUTS

growth of $100 · dividends reinvested · last 3y
DWTX -85.4% (-47.3%/yr)GUTS -97.0% (-69.1%/yr)DWTX compounded faster over this window
050100150Start $10020252026$15$3
DWTX GUTS

DWTX vs GUTS: by the numbers

  • •GUTS is the larger company ($59M vs $52M market cap).

Metrics side by side

Valuation

MetricDWTXGUTS
P/B ratio0.77N/A

Profitability

MetricDWTXGUTS
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-52.72%N/A
ROIC-38.04%-129.67%

Growth (annualized)

MetricDWTXGUTS
Total return CAGR (5Y)-58.44%N/A

Go deeper

Full DWTX analysisFull GUTS analysisInteractive comparison tool

Dig into the metrics

Dogwood Therapeutics ROEFractyl Health ROEDogwood Therapeutics operating marginFractyl Health operating marginDogwood Therapeutics revenue growthFractyl Health revenue growthDogwood Therapeutics free cash flowFractyl Health free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.